会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Pharmacologically Acceptable Salts of Clopidogrel
    • 氯吡格雷的药理学上可接受的盐
    • US20070249660A1
    • 2007-10-25
    • US10590391
    • 2005-02-16
    • Beat WeberMichael LevisHon Ly
    • Beat WeberMichael LevisHon Ly
    • A61K31/4365C07D495/04
    • C07D495/04
    • The invention relates to polymorphous forms of (+)-(S)-clopidogrel hydrogen bromide, described as polymorphous “form A”, polymorphous “form B”, polymorphous “form C”, polymorphous “form D”, polymorphous “form E”, and polymorphous “form F”, in addition to polymorphous forms of (+)-(S)-clopidogrel napsylate, that are described as polymorphous “form A” and polymorphous “form B” and differ in the X-ray powder diffraction diagrams (XRPD) thereof. The invention also relates to the salts clopidogrel besylate, clopidogrel tosylate and clopidogrel oxalate, and to methods for the production thereof.
    • 本发明涉及多形态的(+) - (S) - 氯吡格雷溴化氢,描述为多形态“形式A”,多形态“形式B”,多形态“形式C”,多形态“形式D”,多形态“形式E” ,和多形态“形式F”,以及被描述为多形态“形式A”和多形态“形式B”的(+) - (S) - 氯吡格雷萘磺酸盐的多形态,并且X射线粉末衍射图 (XRPD)。 本发明还涉及盐酸氯吡格雷苯磺酸盐,氯吡格雷甲苯磺酸盐和草酸氯吡格雷及其制备方法。